Upload
vubao
View
225
Download
3
Embed Size (px)
Citation preview
Presentation to
WORLD HALAL RESEARCH
SUMMIT 2010
23rd June 2010
CCM : Championing Halal Pharmaceuticals
By
LEONARD ARIFF ABDUL SHATAR
Director, CCM Pharmaceuticals Division
CHEMICAL COMPANY OF MALAYSIA BERHAD
PHARMACEUTICAL INDUSTRY
Pharmaceutical Industry
• The Pharmaceutical Industry researches, develops, produces, markets and/or distributes licensed medicines.
• Medicine is a substance used to prevent or cure disease or to relieve pain, anxiety or any form of perceived discomfort, categorised as:
– Prescriptive (Ethical) and
– Over-The-Counter (OTC).
MEDICINES HEALTH/DIETARY
SUPPLEMENTS
Innovator Generics
Those provided by the Pharmaceutical Industry will be of the same standard of Safety, Efficacy and Quality as defined for medicines and produced in high hygienic conditions.
Pharmaceutical Industry
Patented products •Off-patent products
The Global Halal PharmaceuticalMarket Potential
>20% of world‟s population are Muslims
Source:
*Frost & Sullivan Market Insight 2 April 2008
**PricewaterhouseCoopers Report 13 June 2007
Map from Wikipedia/CIA-The World Factbook
GLOBAL MARKET VALUE for PHARMA INDUSTRY:
2006 = US$607b*
2013(e) = US$818b*
2020 (f) = US$1,300b**
• Pharmaceutical Industry is HIGHLY REGULATED.
• Companies in this industry are subjected to a
variety of laws and regulations relating to their
products:
– Research & Development (R&D) activities,
– testing methods,
– manufacturing processes,
– marketing, sales and distribution.
Pharmaceutical Industry
Value Chain Analysis
Higher value activities
Current focus of local pharmaceutical industry
A pharmaceutical industry value chain analysis dictates that the highest
value activity resides at the upstream end of the chain.
Presently, the local generics manufacturers (including CCM), are only
focused in Finished Products manufacturing, Sales and Marketing, and
Distribution.
HALAL PHARMACEUTICALS:
AN OVERVIEW
Primary Objectives of Shariah
Preservation
of Faith
Preservation
of Intellect
Preservation
of Progeny
Preservation
of Property
Objectives
of
Shariah
Preservation
of Life
Shariah: Islamic Laws & Ways of Life prescribed by Allah s.w.t
Definition of Halal Pharmaceuticals
SOURCE:
DRAFT MALAYSIAN STANDARD FOR HALAL PHARMACEUTICALS: GENERAL GUIDELINES
DEFINITION OF NAJS
(Pharmaceutical Context)
SOURCE:
DRAFT MALAYSIAN STANDARD FOR HALAL PHARMACEUTICALS: GENERAL GUIDELINES
Halal Products
Halal certified products not only benefit Muslims but
EVERYONE
•SAFE for consumption and use
•HYGIENICALLY processed
•QUALITY standard of production & ingredients/ materials
•Assurance of product EFFICACY
because of the WHOLESOMENESS (“THOYYIBAN”) aspects:
HALAL PHARMACEUTICALS:
INDUSTRY PERSPECTIVE
Halal Pharmaceuticals
source:
Uniqueness of the Pharmaceutical Industry
Consistency in:
products‟ Safety, Efficacy and Quality.
facilities‟ Hygiene standard.
Good Manufacturing Practice (GMP)
Good Hygiene Practice (GHP)
Good Clinical Practice (GCP)
Good Laboratory Practice (GLP)
Good Storage Practice (GSP)
Good Engineering Practice (GEP)
Strictly governed by International Standards of:
Uniqueness of the Pharmaceutical Industry
LAWS OF MALAYSIA
Act 366
POISON ACT 1952
Act 368
SALE OF DRUGS ACT 1952
Act 290
MEDICINES (ADVERTISEMENT AND SALE) ACT 1956
SALE OF FOOD AND DRUGS ORDINANCE 1952
CONTROL OF DRUGS AND COSMETICS REGULATIONS 1984
GMP requirements:
Safety
Efficacy
Quality
Tested
Halal Pharmaceuticals
Tested
Tested
TestedTested
Tested
Tested
Tested
What is the source for these
gelatin capsules?
What is the source for vaccines,
insulin, heparin, etc.?
(Bovine, ovine, porcine, etc.)
Halal Pharmaceuticals
Halal Pharmaceuticals: Traceability
Pharmaceutical Research & Development Process
Chemical Process
Chemicals: The whole range of organic and inorganic chemical products for chemical process and reaction
Catalyst
Pharmaceutical Research & Development Process
Formulation of Final Products
• Pharmaceutical Excipients:– Solvents/co-solvents
– Gel forming agents
– Lubricant, Binder & Disintegrant
– Preservatives
– Dye & pigment
– Minerals, etc
Pharmaceutical Research & Development Process
Rate-limiting Step in Vitamin Production
To prepare Liquid Vitamin into Free-flowing
powders for compressed Tablet or Capsule
Step 1: To mix with combination of:
- Active material (emulsion containing active vitamin material)
- Gelatin + water + gum acacia + sugar and/or starch
Step 2: Collection of individual droplet in a mass of starchy form
Converting emulsion to droplet form
Step 3: Separating the vitamin-active particles from starchy collecting
powder
• Recognition by ingredient suppliers of the
Muslim market
• Recognition that alternatives can be sought
There was a move from bovine into porcine research as
base materials for majority of pharmaceutical products due
to the BSE/mad-cow disease and the porcine based
materials are easily available because of its organised
supply chain for their animal parts in developed countries.
Halal Pharmaceuticals: Industry Impact
HALAL PHARMACEUTICALS:
CONSUMER PERSPECTIVE
“Research shows that some 50% of
medicines prescribed for long term
conditions are not taken as
prescribed ”
From Compliance to Concordance
Royal Pharmaceutical Society of Great Britain, 1997
A Question of Choice:Compliance in Medicine Taking
• Patients not taking medicine is still a major cause of
unnecessary ill health and death.
• Such non-compliance is mostly intentional and
results from a considered decision made by patients
about the benefits and disadvantages of medicines,
rather than just „forgetfulness”
• Patients are much more likely to follow treatment if
they have been active partners in prescribing
decisions and their views and preferences have been
recognised and taken into account.
Task Force on Medicines Partnership 2003
A Question of Choice:Compliance in Medicine Taking
http://www.npc.co.uk/med_partnership/resource/our-publications/drugs-of-porcine-origin.html
Content:
INFORMED CHOICE IN MEDICINE TAKING
The Medicines Partnership Programme was established by the Department of Health, United
Kingdom in 2002 and has promoted the concept of concordance – or shared decision-making
- as an approach to help patients to get the most from their medicines.
INFORMED CHOICE IN MEDICINE TAKING
- THE NPC UK APPROACH
EXCERPTS
NPC UK = National Prescribing Centre (United Kingdom)
EXCERPTS
INFORMED CHOICE
IN MEDICINE TAKING
- THE NPC UK APPROACH
NPC UK = National Prescribing Centre (United Kingdom)
INFORMED CHOICE
IN MEDICINE TAKING
- THE NPCB MALAYSIA APPROACH
NPCB = National Pharmaceutical Control Bureau
To declare by Sept ‟09
Source/Origin for :
1.API and Excipients
2.Hard (Empty) Gelatin Capsules
3.Soft gelatin capsules
Findings:
1. Capsules declared as non-animal sourced contained bovine/
porcine elements
2. Capsules declared as bovine-sourced contained porcine or
combination of bovine and porcine elements
• Consumers are now more knowledgeable/
discerning
• Information on Halal and health matters are
easily accessible on the internet
• Halal agenda is gaining greater prominence
Halal Pharmaceuticals:Consumers’ Informed Choice
HALAL PHARMACEUTICALS:
CCM‟S ROLE
About CCM: History
1930s
1960s
Incorporated on 7th August 1963 as a subsidiary of ICI PLC
Listed on the Main Board of Bursa Malaysia since 1966
Trading arm
1990s
2000s
Became a full-fledged Malaysian company
in 1994 via a Management-Buy-Out (MBO)
exercise
Became a subsidiary
of PNB in 2005
69.54%
10.02%
Others
CCM’s Current Equity Structure
CCM is one of
Malaysia‟s Top GLCs(Government Linked Companies)
1.97%
As at 31st May 2010
Manufactures and
markets general and
specialty chemicals,
as well as provides
services to the public
and manufacturing
sectors
Manufactures and
markets a complete
range of fertilizers
for all crop needs
and conducts soil
testing and progress
developments that
benefit farmers
Develops, manufactures
and markets generic
medicines and over-the-
counter (OTC) health/
dietery supplements &
healthcare products
Supports focused
markets:
•Singapore
•Indonesia
•Thailand
•Philippines
•Vietnam
CCM Group Structure
CCM’S HALAL INITIATIVES
“FARDH KIFAYAH”[COLLECTIVE OBLIGATION/DUTY]
CCM’s Halal Journey
2009
CCM:
CHAMPIONING THE HALAL PHARMACEUTICALS
THE GUIDING PRINCIPLE
A formalised framework to spearhead the Halal Strategy
CCM’s Halal Initiatives
TASK DESCRIPTION RESPONSIBILITY OF:
Stewardship Custodian of the Halal agenda CCM‟s Chairman &
Board of Directors
Ownership &
Leadership
Strategic decision makers that:
validate and own the strategy to boost the
Halal agenda
provide strategic guidance for the
implementation process
CCM Halal Council
chaired by
Group Managing
Director
Performance
Driver
Core Team that:
plans and executes development plans
guides and facilitates development of
action plans
monitors implementation progress
CCM Halal
Committees
chaired by
Division Directors
CCM Halal Policy
Commitment to manufacture,
import and distribute
consumable products that
comply with Halal
requirements.
Assurance that the non-
consumable products which we
manufacture, import and
distribute meet the same high
standards.
Assurance that our production
and supply chain processes
adhere to the high standards.
CAPACITY
BUILDING
HALAL INTEGRITY
MARKETING
“FARDH KIFAYAH”
SHARED RESPONSIBILITY
CCM’s Halal Initiatives: Key Focus
INFORMED
CHOICE
HALAL INTEGRITY
Operating in a socially responsible and ethical manner
Convergence of Minds – Shariah and Science
RITUAL CLEANSING
(SAMAK/SERTU)
This exercise is to ensure that all our equipment used in
production operations are clean and certified pure as per
the Shariah/Halal requirement whilst still meeting GMP*-
Pharmaceutical premise requirements.
CCM’s Key Focus: Halal Integrity
*GMP = Good Manufacturing Practices
Strategic collaboration with key Halal Industry Organisations:
• Relevant Ministries– Prime Minister‟s Office- Department
of Islamic Development (JAKIM), Health Ministry, Trade
Ministries (Domestic and International)
• Government Bodies/Agencies – Standards Malaysia, Halal
Industry Development Corporation (HDC), SIRIM
• Malaysian Universities – UPM, USM, IIUM, UM
• World Halal Forum
• IHI Alliance
CCM’s Key Focus: Halal Integrity
As a pre-cursor for the development of the Halal Pharmaceutical
Standard, CCM had recently supported HDC in conducting the:
CCM’s Key Focus: Halal Integrity
This FIRST Halal Pharmaceutical Audit Workshop, was attended by key
organisations:
Regulatory BodyNational Pharmaceutical Control Bureau, Ministry of Health,
Malaysia
Shariah JAKIM (Department of Islamic Development Malaysia)
Standards1. SIRIM
2. Standards Malaysia
Industry Selected CCM Halal Council and CCM Halal Committee members
Speakers 1. Science scholars from reputable universities
2. Innovax - CCM’s R&D Centre
Facilitators Halal Integrity Division, HDC
CCM’s Key Focus: Halal Integrity
1. The 1st Technical Committee meeting, chaired by the Director-General
of JAKIM was held on 29th September 2009. CCM is a member.
2. Sub-committee was formed to draft the standard, comprising members
from Ministry of Health, Pharmacy Scholars, Pharmaceutical Industry
players. CCM is also a member.
3 meetings had been held to date :
16th October 2009 – initiator, science scholars & regulatory
authorities
4th November 2009 – regulatory authorities & science scholars
5th November 2009 – industry players, regulatory authorities &
science scholars
14th June 2010 - industry players, regulatory authorities &
science scholars
3. The Halal Pharmaceutical Standard is drafted with reference to the
PIC/S* GMP** Guidelines.
*PIC/S = Pharmaceutical Inspection Co-operation Scheme
** GMP = Good Manufacturing Practices
CCM’s Key Focus: Halal Integrity
Halal Pharmaceutical Standard
HALAL
PHARMACEUTICALS
STANDARD
APPROVED
HALAL MATERIAL
LIST
SHARIAHGMP
(PIC/S GUIDELINES)
ALIGNMENT
TRAINING/KNOWLEDGE SHARING
CCM‟s Halal Awareness Programme:
1. Halal Awareness Roadshows & Workshops for
Employees
2. Halal Awareness Seminar for Suppliers
3. Halal Talks for Customers
4. Dialogue Sessions with regulatory authorities/
related bodies
KNOWLEDGE = COMMITMENT & SINCERITY
CCM’s Key Focus: Halal Integrity
CAPACITY BUILDING
Increasing range of Halal
certifiable products
CCM Pharmaceuticals Division: Manufacturing Facilities - Sites
Klang
Shah Alam
Bangi
CCM Pharmaceuticals Division: Manufacturing Facilities - Capacity
Oral Solid
Dosage (OSD) Capacity
Tablets 3 billion
Capsules 300 million
Softgel 144 million capsules
Sterile Production Capacity
Ampoules 36 million ampoules
Dental cartridges 7.4 million vials
Vials liquids 3.6 million vials
Eye drops 168,000 litres
Haemodialysis 5 million litres
Irrigation solution 3 million litres
Penicillin Capacity
Tablets 55 million
Capsules 115 million
Powder 72,000 kg
Cephalosporin Capacity
Tablets 144 million
Capsules 36 million
Powder 72,000 kg
SVI vials 2.5 million vials
Other Dosage
Form Capacity
Liquid 2 million litres
Cream 72,000 kg
1
st
1
st1st
IBC The
only
in
ASEAN
OTHER SIGNIFICANT 1ST IN MALAYSIA
1st SVI (Small Volume Injectibles)
1st Dental Cartridge
1st Soft Gel
1st Patent
• Controlled Release mini-tabs in capsules
1st state-of-art IBC plant
COMING SOON
1st Halal Vaccines F& F
1st Halal Bio-similar
INCREASING HALAL CERTIFIED PRODUCTS
CHEMICAL &
ANALYTICAL
DEPT
FORMULATION &
BIO-PHARMACEUTICAL
DEPT
QUALITY
DEPT
DRUG INFORMATION
PIPELINE
DEPT
HEAD[Medical Doctor with PhD/Doctorate
in Pharmacology]
Core competency in research &
development of special oral
dosage forms/ in-drug delivery
system:
Controlled Release (CR)/
Sustained Release (SR)
CCM Pharmaceuticals Division: R&D Centre
1999
= 38 productsNOW
= 178 products
INCREASING HALAL CERTIFIED PRODUCTS
HALAL PHARMACEUTICALS:
THE WAY FORWARD
Pharmaceutical Industry
MEDICINESHEALTH/DIETARY
SUPPLEMENTS• For wellness, immunity and
energy
• A preventive healthcare option
They are constantly in demand……
…regardless of economic conditions
Halal Pharmaceuticals
• Healing is achieved by medicine when the soul
readily accepts it and believes in its usefulness
and in the blessing of healing which Allah s.w.t.
has put into it.
• What is beneficial is that which is blessed and the
most beneficial is that with the greatest blessing.
• And blessed among the people is he from whom
benefit comes wherever he may be.
Ibn Qayyim Al-Jawziyya: Medicine of the Prophet
Halal Pharmaceuticals
“Indeed Allah s.w.t. sent down both illness and
medicine, and for every illness He gave remedy. So
carry out medical treatment, but do not use therein
anything unlawful”Saying of the Prophet Muhamad – Hadith of Abu al-Darda
“The Messenger of Allah s.w.t. forbade medication
with impure medicines ”Sunnah of the Prophet Muhamad – from Abu Hurayra
“Allah s.w.t. did not place your healing in anything
which has been made unlawful for you ”Saying of the Prophet Muhamad – Hadith of Ibn Mas’ud
Conclusion
1. Halal Pharmaceutical is the emerging growth sector
in the Halal industry.
2. There are still a lot of matters to address in terms of
Halal compliance in this industry, and also the
acceptance of the necessity of its Halal certification,
but with good collaboration:
Together
Everyone
Achieves
More